Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.170
+0.120 (5.85%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Vistagen Therapeutics Market Cap

Vistagen Therapeutics has a market cap or net worth of $62.92 million as of April 23, 2025. Its market cap has decreased by -53.80% in one year.

Market Cap
62.92M
Enterprise Value
-23.93M
1-Year Change
-53.80%
Ranking
Category
Stock Price
$2.17

Market Cap Chart

Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $62.92M, an increase of 576.55%. That is a compound annual growth rate of 23.80%.

History

DateMarket Cap% Change
Apr 22, 202559.20M-27.89%
Dec 31, 202482.10M-40.89%
Dec 29, 2023138.90M552.11%
Dec 30, 202221.30M-94.53%
Dec 31, 2021389.40M171.17%
Dec 31, 2020143.60M381.88%
Dec 31, 201929.80M-36.05%
Dec 31, 201846.60M258.46%
Dec 29, 201713.00M-58.47%
Dec 30, 201631.30M236.56%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 728.58B
UnitedHealth Group 391.26B
Johnson & Johnson 376.51B
AbbVie 299.66B
Novo Nordisk 284.50B
Abbott Laboratories 223.76B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings